Evan Kearns

General Counsel, Agenus.

Companies

Cogent Biosciences, Inc.General counsel May 5, 2021 to now¹
AgenusGeneral counsel Jul 13, 2018 to Dec 21, 2020²
AgenusOfficer Dec 27, 2019 to Dec 27, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cogent Biosciences, Inc. COGT109,398 shares⁴$3.2M at $29.52Dec 26, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 26, 2025Sold 65,000 shares at $38.70 of Cogent Biosciences, Inc.⁴
Dec 17, 2025Shares withheld for tax 125,602 shares at $39.45 of Cogent Biosciences, Inc.⁵
Dec 17, 2025Granted 260,000 shares of Cogent Biosciences, Inc.⁵
Dec 17, 2025Granted 40,000 shares of Cogent Biosciences, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCogent Biosciences, Inc., General counsel
2
SEC EDGARAgenus, General counsel
3
SEC EDGARAgenus, Officer
4
SEC EDGARCogent Biosciences, Inc. shares after the filing of Dec 26, 2025
5
SEC EDGARForm 4 filed Dec 19, 2025